Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation
KCHRF-DASH-AF-0002
Approved small_molecule active
Quick answer
Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation for Arrhythmias, Cardiac is a Approved program (small_molecule) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rhythm Pharmaceuticals Netherlands B.V.
- Indication
- Arrhythmias, Cardiac
- Phase
- Approved
- Modality
- small_molecule
- Status
- active